Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Prescription Coverage Coalition Reveals PBM & Unique Contract Terms
  • USA - English


News provided by

The National Prescription Coverage Coalition

Sep 18, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX


Morristown, New Jersey (PRWEB) September 18, 2014 -- The National Prescription Coverage Coalition today announced that it has executed a contract with the PBM Envision Pharmaceutical Services, which has agreed to provide services to all new Coalition Members based on a unique contract that will dramatically reduce Coalition Members' costs.

Compare the Coalition's contract terms with Envision with your own PBM contract terms, and you'll immediately realize why joining the Coalition will result in dramatically lower prescription coverage costs.

Post this

Accordingly, by joining the Coalition, every corporate, union and municipal health plan sponsor will benefit immediately simply by taking advantage of the Coalition's already-negotiated, unique contract terms, which are detailed on the Coalition's website.

The Coalition's Unique Specialty Drug Terms

"Every plan is struggling to control the costs of Specialty Drugs, which represent 1% to 3% of all drugs taken, but 15% to 25% of total drug costs," explained Linda Cahn, the Coalition’s Executive Director. "The Coalition's contract with Envision mandates a Minimum Discount Guarantee for every Specialty Drug in the marketplace - a total of 850+ drugs."

The importance of the Coalition's aggressive Specialty Drug pricing is clear, added Cahn.

"Most PBM / client contracts today provide guaranteed discounts on only about 100 to 200 Specialty Drugs. A few contracts offer discounts on 400 to 500 Specialty Drugs. But that still leaves PBMs free to charge inflated prices on hundreds of Specialty Drugs. Moreover, almost no contracts contain any price controls over new-to-market Specialty Drugs,” said Cahn.

As Cahn further explained: “Unless every Specialty Drug has a guarantee - and the guarantee is aggressive - your plan's costs are unlikely to be contained and instead will likely skyrocket.”

The Coalition's Unique Generic Drug Guarantees

The Coalition's executive director also revealed how the Coalition’s contract will ensure that every Coalition Member will obtain lower generic drug costs as a result of another set of unique contract guarantees.

The Coalition's contract contains two, different generic drug Ingredient Cost guarantees – for each of the 3 pharmacy venues (retail, retail 90 and mail) - meaning 6 such guarantees in total. The first type of guarantee is for those generic drugs that have just entered the market, when the generic drugs are typically quite expensive. The second type of guarantee, which is far more aggressive, is for all other Generic Drugs. By subdividing generic drugs between those two categories, the contract provides far stronger guarantees for virtually all generic drugs.

The contract also contains unique Commonly Used Generic Drug Guarantees. Linda Cahn explained why: "Unbeknownst to most PBM clients, PBMs routinely charge their clients an average of $80 to $100 per prescription for the generic versions of drugs like Lipitor, Prozac and Zoloft, but those drugs should have average costs of no more than $15 to $25 per prescription." Cahn added: "Given PBMs' inflated prices, when plans create incentivizes for their members to use low-cost generic drugs, it's PBMs - not plans - that reap the largest financial benefits." The Coalition's Maximum Price Guarantees for certain Commonly Used Generic Drugs will protect every Coalition Member from PBMs' typical price gouging on these Commonly Used Generic Drugs.

Linda Cahn also described the savings that will result from the Coalition’s contract terms concerning Prior Authorization, Step Therapy and Quantity Limit Programs. Envision has agreed to provide far more extensive reporting, including detailed approval/disapproval Prior Authorization reports. And the Coalition has the right to carve-out any of these Programs and rely on a third party vendor, should the Coalition want to do so.

Envision’s Unique Rebate Terms

Envision also agreed to provide every Coalition Member with a 100% pass-through of all financial benefits – not just rebates – from all third parties – not just drug manufacturers.

Moreover, unlike all other PBMs, Envision agreed to pass through all third party financial benefits that are earned during an Invoice period, when each Invoice is transmitted.

Thus, rather than waiting for the usual 9 to 15 months to collect rebates, every Coalition Member will collect not only rebates, but all other third party financial benefits in a timely fashion.

Coalition Member Benefits

Unlike other Coalitions, the National Prescription Coverage Coalition will be providing its Coalition Members with ongoing and continuous services from the Coalition's staff of experts.

The Coalition will conduct an automatic Set-Up Audit after each Coalition Member begins coverage to try to ensure that every Coalition Member's Benefit Plan Design is accurately loaded into the PBM's computer systems.

Coalition experts will also scrutinize an extensive set of claims data for every Coalition Member every month. That task can be accomplished because the Coalition's contract mandates that a complete set of claims data must accompany every Invoice and must be transmitted to every Coalition Member - as well as to the Coalition's experts - or the Invoice need not be paid.

Coalition experts will also continuously (i) review available pricing for new - and old - Generic Drugs and Specialty Drugs, (ii) negotiate quarterly with Envision to update and improve pricing, and (iii) work with Coalition Members continuously to tailor their Savings Programs to adjust to marketplace changes.

"Given the ongoing and relentless changes that are taking place in the drug marketplace, clients can't possibly keep up with all the information that's needed to control their costs," said the Coalition's executive director Linda Cahn. "But our Coalition experts will do so, and will be in regular contact with every Coalition Member to make sure each is positioned to react to new developments to control its costs."

The Coalition is offering a free consultation to every corporation, union and municipal entity that wants to learn more about the Coalition's unique arrangement with Envision. "We are confident if you compare the Coalition's new contractual terms to those being offered by any other PBM in the marketplace, you'll quickly realize why joining the Coalition will result in dramatically lower prescription coverage costs," says Cahn.

For more information about the National Prescription Coverage Coalition, contact the Coalition at 973 975-0900 or visit the Coalition's website.

A detailed description of the Coalition Services that will be provided to all Coalition Members can also be found on the Coalition's website.    

Entities that want to obtain tips on how to control prescription coverage costs can also sign up on the website to receive Free $$$-Saving Drug Alerts.

About Envision Pharmaceutical Services

Established in 2001, Envision Pharmaceutical Services (EnvisionRxOptions) is a national, full-service pharmacy benefit management company. A portfolio company of TPG, a leading global private investment firm with $66 billion of assets under management, Envision is part of a group of healthcare management companies owned and operated by Envision Pharmaceutical Holdings LLC (EPH), a privately held company with consolidated revenues in excess of $4 billion.

EPH subsidiaries include (i) Envision Insurance Company, a fully insured provider of Medicare Part D Plans nationally; (ii) Envision Medical Solutions, LLC, an administrator of prescription savings plans and Prescription Savings Cards; (iii) Orchard Pharmaceutical Services, LLC, a full-service mail-order and specialty drug pharmacy; and (iv) Design Rx, LLC, a market leader in pharmacy services for infertility and fertility.

Envision - founded on a commitment to provide full transparency and disclosure in the PBM marketplace - employs a transparent, pass-through business model in which 100% of earned rebates, discounts, and incentives are instantly credited at the point of sale to customers, for which Envision charges a low, flat monthly management fee for most services. This translates into significant savings for the company’s more than 20 million covered individuals.

Envision has been awarded the Utilization Review Accreditation Commission (URAC) accreditations for PBM and Drug Therapy Management annually since 2007. Envision is headquartered in Twinsburg, OH, with offices in Fort Lauderdale, FL; Tampa, FL; Canton, OH; El Dorado Hills, CA; and Ogden, UT.

Linda Cahn, The National Prescription Coverage Coalition, http://www.NationalPrescriptionCoverageCoalition.com, +1 (973) 975-0900, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.